Oragenics Inc. Stock
Pros and Cons of Oragenics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Oragenics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Oragenics Inc. | - | - | - | - | - | - | - |
| Solasia Pharma KK | 3.210% | -11.050% | 12.587% | -19.500% | 21.053% | -49.371% | -85.877% |
| Larimar Therapeutics Inc. | -0.900% | 0.000% | 73.228% | 57.143% | 32.530% | -23.478% | -66.917% |
| Vaxart Inc. | 0.000% | -10.317% | 52.703% | 31.825% | 101.786% | -30.230% | -87.500% |
Comments
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat